Health Reform 101: Cashing In On Hidden Financial Aid Provisions
Executive Summary
Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package
You may also be interested in...
Limited Funding For Cures Acceleration Network Has Upside: Partnership Options
Congressional appropriations provide $10 million for the new program to speed development of therapies for “high need” diseases and conditions, substantially less than the $100 million requested by NIH.
NIH Center Would Seek To Boost “Repurposing” Of Shelved Drug Candidates
A proposed new center at the National Institutes of Health dedicated to speeding “translation” of biomedical research into therapies may focus initially on exploring new uses for drug candidates shelved by pharmaceutical firms, according to NIH Director Francis Collins.
NIH Center Would Seek To Boost “Repurposing” Of Shelved Drug Candidates
A proposed new center at the National Institutes of Health dedicated to speeding “translation” of biomedical research into therapies may focus initially on exploring new uses for drug candidates shelved by pharmaceutical firms, according to NIH Director Francis Collins.